Related Experiment Video
Updated: Jun 7, 2026

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
A self-validating quantitative mass spectrometry method for assessing the accuracy of high-content phosphoproteomic
Pedro Casado1, Pedro R Cutillas
1Analytical Signalling Group, Centre for Cell Signalling, Institute of Cancer, Bart's and the London Medical School, Queen Mary University of London, UK.
This study introduces a new liquid chromatography-MS method to accurately assess phosphoproteome data quality. The approach revealed differential phosphorylation in leukemia cells, offering insights into kinase inhibitor resistance.
Area of Science:
- Cellular biology
- Biochemistry
- Proteomics
Background:
- Protein kinase pathways are crucial for cell signaling.
- The phosphoproteome reflects kinase pathway activation, making its quantification vital for understanding signaling networks.
- Existing quantitative phosphoproteomics methods lack objective data quality assessment for individual quantified sites.
Purpose of the Study:
- To develop and validate an objective method for assessing data quality in high-content phosphoproteome comparisons.
- To investigate differential phosphorylation patterns in leukemia cell lines with varying sensitivity to kinase inhibitors.
- To evaluate the accuracy and precision of phosphopeptide quantification.
Main Methods:
- A liquid chromatography-mass spectrometry (LC-MS) approach was developed for high-content phosphoproteome comparison.
- Samples were mixed at different proportions to derive a linear regression function for calculating correlation, linearity, and accuracy.
- The method was applied to P31/Fuj and Kasumi-1 leukemia cell lines.
Main Results:
- The developed method objectively assesses phosphoproteome data quality, complementing standard precision calculations.
- Quantified phosphopeptides sometimes lacked precision due to low ion statistics, highlighting the need for accuracy assessment.
- Over 2250 phosphorylation sites were quantified, with 1847 showing < 30% accuracy variation.
- Hundreds of phosphorylation sites showed distinct intensities between sensitive and resistant leukemia cells.
Conclusions:
- The new LC-MS approach provides objective data quality assessment for phosphoproteomics.
- Differential phosphorylation patterns were identified in leukemia cells, correlating with sensitivity to kinase inhibitors.
- These findings suggest distinct kinase pathway regulation in cancer cells with varying drug sensitivities.
More Related Videos
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017